- 1、本文档共8页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Recombinant human endostatin Phase I clinical study
PAGE \* MERGEFORMAT 8
Recombinant human endostatin Phase I clinical study
Author; Tong Zhongsheng, Yan Zhao, Pakistan 1, Shu-Fen Lee, Shi Ye-hui, HE Li-hong, WANG Xu, WANG Chen, Hao Chunfang
[Abstract] Objective To evaluate recombinant human endostatin in human safety and pharmacokinetic characteristics. Methods 27 cases of healthy volunteers were divided into four dose groups, respectively, 30 mg/m2 (3 Li), 60 mg/m2 (8 Li), 120 mg/m2 (8 Li), 180 mg/m2 (8 Li ), all single intravenous infusion of recombinant human endostatin; 16 cases of malignant tumor patients, sub-3 dose groups, respectively, 10 mg/m2 (10 Li), 20 mg/m2 (3 Li), 30 mg / m2 (3 cases), each continuous intravenous infusion of recombinant human endostatin 28 days; 27 cases of healthy volunteers and 10 patients with malignant tumor (10 mg/m2) with the United States Quantikine serum immunoassay kit re - human endostatin concentration for pharmacokinetic studies. The results of the whole group no significant dose-limiting toxicity, a few occur in the heart of some toxicity, such as sinus tachycardia, myocardial ischemia, ventricular contraction, sinus arrhythmia. Other adverse reactions are rash, diarrhea, fever, fatigue. In 16 patients evaluable, MR 1 Li, SD 14 Li, PD 1 Li. Single-dose group Cmax and AUC increased linearly with the dose increased, Vd and Cl is also a corresponding increase with dose; multiple dose groups in a continuous administration of drug trough concentrations of about 1 week to reach steady-state level, used in conjunction 28 days , in the body to maintain the concentration of low and does not produce significant accumulation. Conclusion preliminary observation is effective for treatment of cancer are recommended for Phase Ⅱ clinical trials, the dose for each 10 mg/m2, day 1, continuous administration for 28 days in order to further study of this drug for cancer patients the efficacy and safety.
[Keywords:] recombinant human endostatin; Ⅰ Phase I clinical studies; dos
您可能关注的文档
- Rapid prototyping technology in the mandibular defect Application.doc
- Rapid sterilization of medical devices for orthopedic equipment sterilization Effect.doc
- Rapid recovery in the perioperative surgical nursing concepts and applications.doc
- Rapid detection of organophosphorus pesticide residues Research Progress.doc
- Rapid implementation of the ERP of the five law.doc
- Rapid Identification of starchy vegetables such as Chinese herbal medicine commonly used memory.doc
- Rapid Turbidimetric Determination of Sulfate Polymyxin E potency.doc
- Rapidly changing business environment in the liquor.doc
- Rare actinomycetes plasmid biology research.doc
- Rare actinomycetes produce antibiotics.doc
文档评论(0)